Invention Application
- Patent Title: NOVEL OXAZINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE
-
Application No.: US13592580Application Date: 2012-08-23
-
Publication No.: US20130172331A1Publication Date: 2013-07-04
- Inventor: Rainer Martin LUEOEND , Rainer MACHAUER , Heinrich RUEEGER , Siem Jacob VEENSTRA
- Applicant: Rainer Martin LUEOEND , Rainer MACHAUER , Heinrich RUEEGER , Siem Jacob VEENSTRA
- Assignee: NOVARTIS AG
- Current Assignee: NOVARTIS AG
- Main IPC: C07D413/14
- IPC: C07D413/14 ; A61K31/5355 ; A61K45/06
Abstract:
The invention relates to novel oxazine derivatives of formula (I), and pharmaceutically acceptable salts thereof, in which all of the variables are as defined in the specification, pharmaceutical compositions thereof, combinations thereof, and their use as medicaments, particularly for the treatment of Alzheimer's Disease or diabetes via inhibition of BACE-1 or BACE-2.
Public/Granted literature
- US09163011B2 Oxazine derivatives and their use in the treatment of disease Public/Granted day:2015-10-20
Information query
